Martin, S., Desgardin, A., Feinberg, N., Karrison, T., Keutgen, X., Liao, C. (2026). Phase I study of fulvestrant in combination with
                    <sup>177</sup>
                    Lu-DOTATATE for advanced pancreatic neuroendocrine tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps649